Skip to main content
SpringerLink
Log in

The UK MHRA has announced that products containing pseudoephedrine or ephedrine will retain OTC status,

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Royal Pharmaceutical Society of GB.Decision on Cold and Flu Products Makes Good Consumer Sense. Media Release: 29 Aug 2007. Available from: URL: http://www.prnewswire.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The UK MHRA has announced that products containing pseudoephedrine or ephedrine will retain OTC status,. Pharmacoecon. Outcomes News 536, 11 (2007). https://doi.org/10.2165/00151234-200705360-00031

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705360-00031

Keywords

Search

Navigation